Delivery Order SPE2DR25D1120-SPE2DR26FZ2HT
- Not listed
- The Defense Logistics Agency awarded a $1,279.38 delivery order to AmerisourceBergen Drug Corp for Cryselle-28 tablets on December 9, 2025, with an ultimate completion date of December 10, 2025. This firm fixed-price contract, which is not set-aside, represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,741.91 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Cryselle-28 tablets. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion and extending through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $7,221.73 to AmerisourceBergen Drug Corp for Cryselle-28 tablets on April 22, 2025, with an ultimate completion date of April 23, 2025. The contract employs firm fixed price pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428....
- This delivery order, awarded July 14, 2025, represents a $7,016.52 firm fixed-price contract issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Cryselle-28 tablets. The contract is set to be completed by July 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award is a non-set-aside, competitively awarded contract that leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC)...
- This delivery order, valued at $2,023.19, was awarded to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Cryselle 0.3-0.03 contraceptive medication. The contract is non-competitive and represents a child order under a larger Indefinite Delivery Contract vehicle with the Defense Logistics Agency Troop Support Medical. Performance will occur at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 26, 2025. This award was...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,702.12, is for the delivery of CRYSELLE-28 TABLET 28S medical supplies. The contract has an ultimate completion date of February 13, 2025 and is a firm fixed-price contract type. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitive delivery order valued at $2,324.60 from the Defense Logistics Agency's Medical Supply Chain on September 4, 2025. Designated as a firm fixed-price contract with no set-aside provisions, this delivery order is structured as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $237,884.64 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on December 11, 2025, with an ultimate completion date of December 12, 2025. This non-set-aside contract represents a child delivery order issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug...
- This delivery order, valued at $33,710.13, was awarded on December 17, 2025, to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) under a firm fixed price contract with an ultimate completion date of December 17, 2025. The order represents a child delivery against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement running through December 2026. No set-aside was utilized for this...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $27,999.27 delivery order by the Defense Logistics Agency's Medical Supply Chain on July 24, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The company serves as a critical pharmaceutical distributor for federal medical...
- SPE2DR25D1120Indefinite Delivery Contract
- SPE2DR25D1120-SPE2DR26FZ2HTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,361.20 to AmerisourceBergen Drug Corp for Cryselle-28 tablets (28-count packaging) on December 17, 2025, with an ultimate completion date of December 18, 2025. This is a firm fixed-price, non-set-aside contract for pharmaceutical delivery to support federal medical procurement needs. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates extensive capability in delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. All of AmerisourceBergen's reviewed federal awards have been competitively awarded without set-asides, reflecting the company's ability to meet federal procurement requirements through open competition. The Cryselle-28 delivery fulfills the company's role in supporting military medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 12/16/25 |